KPIs & Operating Metrics(New)
Growth Metrics

Illumina (ILMN) Cash & Equivalents (2016 - 2026)

Illumina filings provide 18 years of Cash & Equivalents readings, the most recent being $1.1 billion for Q1 2026.

  • On a quarterly basis, Cash & Equivalents fell 2.16% to $1.1 billion in Q1 2026 year-over-year; TTM through Mar 2026 was $1.1 billion, a 2.16% decrease, with the full-year FY2025 number at $1.4 billion, up 25.82% from a year prior.
  • Cash & Equivalents hit $1.1 billion in Q1 2026 for Illumina, down from $1.4 billion in the prior quarter.
  • In the past five years, Cash & Equivalents ranged from a high of $2.0 billion in Q1 2023 to a low of $869.0 million in Q3 2024.
  • Median Cash & Equivalents over the past 5 years was $1.1 billion (2024), compared with a mean of $1.2 billion.
  • Biggest five-year swings in Cash & Equivalents: plummeted 69.52% in 2022 and later skyrocketed 63.23% in 2023.
  • Illumina's Cash & Equivalents stood at $1.0 billion in 2022, then increased by 4.8% to $1.0 billion in 2023, then rose by 7.54% to $1.1 billion in 2024, then grew by 25.82% to $1.4 billion in 2025, then decreased by 23.2% to $1.1 billion in 2026.
  • The last three reported values for Cash & Equivalents were $1.1 billion (Q1 2026), $1.4 billion (Q4 2025), and $1.0 billion (Q3 2025) per Business Quant data.